Literature DB >> 35986754

Use of extracorporeal membrane oxygenation in massive amlodipine overdose.

Ian Zhirui Hong1, Mingwei Ng2, Duu Wen Sewa3, Yi Ju Yao4, Mathew Chakaramakkil Jose5, Kenneth Boon Kiat Tan1, R Ponampalam1.   

Abstract

Calcium-channel blocker overdose can result in profound vasoplegia and cardiogenic shock, which can quickly spiral into multi-organ failure and death. In this case report, we discuss two separate cases of massive amlodipine overdose with polydrug intoxication (Patient A: amlodipine and quetiapine; Patient B: amlodipine, fluoxetine and zopiclone), both of which were complicated by life-threatening vasoplegic shock refractory to supportive therapy (endotracheal intubation, fluid resuscitation, activated charcoal, vasopressors and inotropes), multimodal antidotes (calcium and hyper-insulinemic euglycemic therapy) and even second-line treatment (methylene blue and therapeutic plasma exchange). Despite exhausting all therapeutic options, resuscitation remained futile with no clinical response elicited until veno-arterial extracorporeal membrane oxygenation (ECMO) salvage therapy was initiated in both cases as a bridge-to-recovery. Albumin dialysis was also commenced to further enhance elimination of amlodipine given its high plasma protein-binding properties. Both patients improved drastically once perfusion to vital organs was maintained by ECMO and eventually survived with good neurological outcomes and preserved cardiac contractility on discharge. This case report supports the growing evidence that although ECMO support represents a potentially life-saving salvage therapy for refractory poisoning-induced shock, escalation to ECMO must be considered and instituted early before irreversible multi-organ failure sets in to ensure good clinical outcomes.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Albumin dialysis; Amlodipine; Calcium channel blocker overdose; ECMO; Poisoning

Mesh:

Substances:

Year:  2022        PMID: 35986754     DOI: 10.1007/s00204-022-03364-5

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   6.168


  5 in total

Review 1.  Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies.

Authors:  Andis Graudins; Hwee Min Lee; Dino Druda
Journal:  Br J Clin Pharmacol       Date:  2015-10-30       Impact factor: 4.335

2.  Methylene blue in the treatment of refractory shock from an amlodipine overdose.

Authors:  David H Jang; Lewis S Nelson; Robert S Hoffman
Journal:  Ann Emerg Med       Date:  2011-05-05       Impact factor: 5.721

Review 3.  Use of methylene blue in sepsis: a systematic review.

Authors:  Edmund S H Kwok; Daniel Howes
Journal:  J Intensive Care Med       Date:  2006 Nov-Dec       Impact factor: 3.510

Review 4.  An Overview of Hyperinsulinemic-Euglycemic Therapy in Calcium Channel Blocker and β-blocker Overdose.

Authors:  James R Krenz; Yaman Kaakeh
Journal:  Pharmacotherapy       Date:  2018-10-04       Impact factor: 4.705

5.  Hemostasis management and therapeutic plasma exchange: Results of a practice survey.

Authors:  Nicole D Zantek; Leonard I Boral; Yanhua Li; Chisa Yamada; Annika M Svensson; Jason E Crane; Roy E Smith; Monica B Pagano; Marian A Rollins-Raval; Amy E Schmidt; Edward C C Wong; Yanyun Wu
Journal:  J Clin Apher       Date:  2018-09-12       Impact factor: 2.821

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.